CureVac N.V. (5CV.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 677.62M |
| Enterprise Value | 234.84M |
| P/E Ratio | 5.68 |
| PEG Ratio | 0.41 |
| Price/Sales Ratio | 16.36 |
| Price/Book Ratio | 1.06 |
| Enterprise/Revenue | 9.58 |
| Enterprise/EBITDA | 2.5 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | 2.87 |
| Operating Margin | 3.44 |
AD
Management Effectiveness
| Return On Assets | 0.14 |
| Return On Equity | 0.23 |
Income Statement
| Revenue | 535.18M |
| Revenue/Share | 0.25 |
| Gross Profit | 429.35M |
| EBITDA | 209.69M |
| Net Income | 162.19M |
| Diluted EPS | 0.72 |
Balance Sheet
| Total Cash | 419.21M |
| Total Cash/Share | 1.86 |
| Total Debt | 35.07M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 3.7 |
| Book Value Per Share | 3.87 |
Price History
| 52-Week Change | 12.89 |
| 52-Week High | 4.9 |
| 52-Week Low | 2 |
| Moving Average 50 Days | 4.29 |
| Moving Average 200 Days | 4.17 |
Statistics
| Average Volume | 168,173 |
| Shares Outstanding | 225.17M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
